Matches in SemOpenAlex for { <https://semopenalex.org/work/W2115585318> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2115585318 endingPage "294" @default.
- W2115585318 startingPage "291" @default.
- W2115585318 abstract "The emergence of multidrug-resistant tuberculosis (MDR-TB) is a major global concern since, despite a complex treatment regime, it still remains a lethal threat. A 21-yr-old male HIV-negative migrant from Burma presented with a disseminated tuberculosis affecting the lung, spleen, liver, mediastinal and abdominal lymph nodes. This particular strain of Mycobacterium tuberculosis proved to be resistant to all but one (pyrazinamide) of the first-line drugs, i.e. rifampicin, isoniazid and ethambutol, plus streptomycin, rifabutin and ofloxacin. On the mere account of its susceptibility concerning kanamycin it could not be labelled as extensively drug-resistant tuberculosis. After 1month of a standard first-line four-drug regimen and a subsequent 4months of second-line treatment with amikacin, moxifloxacin, terizidone, protionamide, linezolid and pyrazinamide, sputum cultures eventually yielded constantly negative results. Likewise, the organ manifestations decreased significantly, so as to be virtually undetectable in computed tomography scans after 1yr of continuous treatment. A moderate pancytopenia reversed completely after dose adjustment of linezolid. Disseminated tuberculosis manifestations without typical pulmonary cavernous lesions are likely to represent primary infection rather than reactivation. Even a multiorgan disseminated MDR-TB with an extensive resistance pattern (including fluoroquinolones) can be successfully treated with an individual second-line treatment and result in considerably few adverse events." @default.
- W2115585318 created "2016-06-24" @default.
- W2115585318 creator A5018017419 @default.
- W2115585318 creator A5051316885 @default.
- W2115585318 date "2009-11-30" @default.
- W2115585318 modified "2023-09-23" @default.
- W2115585318 title "Disseminated multiorgan MDR-TB resistant to virtually all first-line drugs" @default.
- W2115585318 cites W1239989244 @default.
- W2115585318 cites W19265322 @default.
- W2115585318 cites W2038091313 @default.
- W2115585318 cites W2049723770 @default.
- W2115585318 cites W2085282522 @default.
- W2115585318 cites W2090542083 @default.
- W2115585318 cites W2103230556 @default.
- W2115585318 cites W2135027892 @default.
- W2115585318 cites W2136694704 @default.
- W2115585318 cites W2144362977 @default.
- W2115585318 doi "https://doi.org/10.1183/09059180.00002109" @default.
- W2115585318 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20956153" @default.
- W2115585318 hasPublicationYear "2009" @default.
- W2115585318 type Work @default.
- W2115585318 sameAs 2115585318 @default.
- W2115585318 citedByCount "3" @default.
- W2115585318 countsByYear W21155853182013 @default.
- W2115585318 countsByYear W21155853182014 @default.
- W2115585318 crossrefType "journal-article" @default.
- W2115585318 hasAuthorship W2115585318A5018017419 @default.
- W2115585318 hasAuthorship W2115585318A5051316885 @default.
- W2115585318 hasConcept C126322002 @default.
- W2115585318 hasConcept C142724271 @default.
- W2115585318 hasConcept C2776228421 @default.
- W2115585318 hasConcept C2776409635 @default.
- W2115585318 hasConcept C2776962512 @default.
- W2115585318 hasConcept C2776967927 @default.
- W2115585318 hasConcept C2777975735 @default.
- W2115585318 hasConcept C2778607973 @default.
- W2115585318 hasConcept C2778836808 @default.
- W2115585318 hasConcept C2778980435 @default.
- W2115585318 hasConcept C2779489039 @default.
- W2115585318 hasConcept C2780459521 @default.
- W2115585318 hasConcept C2780867798 @default.
- W2115585318 hasConcept C2781069245 @default.
- W2115585318 hasConcept C2781414143 @default.
- W2115585318 hasConcept C501593827 @default.
- W2115585318 hasConcept C523546767 @default.
- W2115585318 hasConcept C54355233 @default.
- W2115585318 hasConcept C71924100 @default.
- W2115585318 hasConcept C86803240 @default.
- W2115585318 hasConcept C89423630 @default.
- W2115585318 hasConceptScore W2115585318C126322002 @default.
- W2115585318 hasConceptScore W2115585318C142724271 @default.
- W2115585318 hasConceptScore W2115585318C2776228421 @default.
- W2115585318 hasConceptScore W2115585318C2776409635 @default.
- W2115585318 hasConceptScore W2115585318C2776962512 @default.
- W2115585318 hasConceptScore W2115585318C2776967927 @default.
- W2115585318 hasConceptScore W2115585318C2777975735 @default.
- W2115585318 hasConceptScore W2115585318C2778607973 @default.
- W2115585318 hasConceptScore W2115585318C2778836808 @default.
- W2115585318 hasConceptScore W2115585318C2778980435 @default.
- W2115585318 hasConceptScore W2115585318C2779489039 @default.
- W2115585318 hasConceptScore W2115585318C2780459521 @default.
- W2115585318 hasConceptScore W2115585318C2780867798 @default.
- W2115585318 hasConceptScore W2115585318C2781069245 @default.
- W2115585318 hasConceptScore W2115585318C2781414143 @default.
- W2115585318 hasConceptScore W2115585318C501593827 @default.
- W2115585318 hasConceptScore W2115585318C523546767 @default.
- W2115585318 hasConceptScore W2115585318C54355233 @default.
- W2115585318 hasConceptScore W2115585318C71924100 @default.
- W2115585318 hasConceptScore W2115585318C86803240 @default.
- W2115585318 hasConceptScore W2115585318C89423630 @default.
- W2115585318 hasIssue "114" @default.
- W2115585318 hasLocation W21155853181 @default.
- W2115585318 hasLocation W21155853182 @default.
- W2115585318 hasOpenAccess W2115585318 @default.
- W2115585318 hasPrimaryLocation W21155853181 @default.
- W2115585318 hasVolume "18" @default.
- W2115585318 isParatext "false" @default.
- W2115585318 isRetracted "false" @default.
- W2115585318 magId "2115585318" @default.
- W2115585318 workType "article" @default.